Huge positive for Ranbaxy

Latest Strong buzz on streets –

Dilip Sanghvi of Sun Pharma has acquired additional 2% stake in the company in the past 15 days thereby totaling close to 5%.

Sun Pharma and Ranbaxy are going to announce strategic tie up soon .

Ranbaxy will use the FDA approved manufacturing facilities of Sun Pharma to supply drugs to US. In turn Ranbaxy will delist the shares at Rs. 750 per share within a month.

Sources at daichi say that after the recent meeting of commerce ministry, the US FDA officials have assured that the Tonsa plant of Ranbaxy will get approval soon.

SGX Nifty

sgxnifty.org@imediaone.com

You may also like...

Rules of Discussion on Huge positive for Ranbaxy

1. This forum is for discussion of financial markets. Please respect others view even if they are contrary to you.
2. Member's comments should lead to value addition in forum discussion.
3. If anyone is found making repetitive Explicit/Abusive/Racial comments, his account shall be banned and old posts will be deleted.
4. Providing Advice/Recommendations/Tips is fine but it should be free. Members cannot ask to be paid for it. Paid Advice is stricly prohibited
5. Spam links are not allowed. Self-promotion once a week is allowed. Too much promotion or using Contact info in ID will lead to account ban.